Brief: Oncopeptides Q4 Net Loss Narrows To Sek 394.0 Mln
17/02/2022 07:19
Feb 17 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES PUBLISHES YEAR-END REPORT 2021
* Q4 NET SALES AMOUNTED TO SEK -21.7 M (0.0)
* Q4 NET LOSS AMOUNTED TO SEK -394.0 M (-513.0)
Source text for Eikon: ID:nWkrbDP79K
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy